Research summary ·
Evaluating the efficacy and safety of melatonin for sleep onset insomnia in children aged 6-12: a systematic review and meta-analysis.
Written based on 1 research study on PubMed, searched on 13 Nov 2026.
What was studied
This review pooled results from earlier studies on melatonin. Melatonin is a body hormone that helps control sleep and waking. The review looked at kids aged 6-12 who had trouble falling asleep. The team searched several research databases for trials. They found 10 trials that put kids into groups by chance. The pooled results set melatonin against a dummy pill. The team also checked each trial for possible bias.
What they found
Melatonin was linked to an earlier start of sleep than a dummy pill. On average, sleep began about 29 minutes earlier. Melatonin was also linked to less time needed to fall asleep. Results were not the same across the trials. The gap was moderate for one measure and high for the other. The abstract gives no figures for total sleep time or dropouts.
What it means for patients
The authors say melatonin had a clear effect on trouble falling asleep in kids. They report better sleep timing and better total sleep time. They say the gains were both real in the data and real in daily life. In their view, this shows melatonin works and is safe in kids.
Why it is not certain yet
The authors say long-term effects and safety still need study. Results were not the same across trials, so the pooled result is less firm. The abstract gives no numbers on side effects. A review can only be as good as the studies in it.
Source
Evaluating the efficacy and safety of melatonin for sleep onset insomnia in children aged 6-12: a systematic review and meta-analysis.
PubMed · PMID 43015664We restate facts from the source record in our own words. The original wording belongs to its publisher.
This page is not medical advice. Talk to your doctor about your own care.
Back to Insomnia publications